<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">neurojour</journal-id><journal-title-group><journal-title xml:lang="ru">Неврологический журнал имени Л.О. Бадаляна</journal-title><trans-title-group xml:lang="en"><trans-title>L.O. Badalyan Neurological Journal</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2686-8997</issn><issn pub-type="epub">2712-794X</issn><publisher><publisher-name>ФГАУ «НМИЦ здоровья детей» Минздрава России</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.46563/2686-8997-2020-1-4-208-216</article-id><article-id custom-type="elpub" pub-id-type="custom">neurojour-15</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>Неопластический потенциал при пороках развития экто- и мезодермальных структур</article-title><trans-title-group xml:lang="en"><trans-title>Neoplastic potential for malformations of the development of ecto- and mesodermal structures</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Цоцонава</surname><given-names>Жужуна Мурмановна</given-names></name><name name-style="western" xml:lang="en"><surname>Tsotsonava</surname><given-names>Zhuzhuna M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кандидат мед. наук, доц. кафедры неврологии и нейрохирургии с курсом последипломного образования ФГБОУ ВО «Астраханский государственный медицинский университет» Минздрава России, 414000, Астрахань.</p><p>e-mail: tsotsonava02@yandex.ru</p></bio><bio xml:lang="en"><p>MD, Ph.D., Associate of the Department of Neurology and Neurosurgery with a course of postgraduate education of the Astrakhan State Medical University, Astrakhan, 414000, Russian Federation.</p><p>e-mail: tsotsonava02@yandex.ru</p></bio><email xlink:type="simple">tsotsonava02@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Белопасов</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Belopasov</surname><given-names>Vladimir V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5203-3600</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ткачева</surname><given-names>Н. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Tkacheva</surname><given-names>Natal’ya V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">ФГБОУ ВО «Астраханский государственный медицинский университет» Минздрава России<country>Россия</country></aff><aff xml:lang="en">Astrakhan State Medical University<country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>29</day><month>03</month><year>2021</year></pub-date><volume>1</volume><issue>4</issue><fpage>208</fpage><lpage>216</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Цоцонава Ж.М., Белопасов В.В., Ткачева Н.В., 2021</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="ru">Цоцонава Ж.М., Белопасов В.В., Ткачева Н.В.</copyright-holder><copyright-holder xml:lang="en">Tsotsonava Z.M., Belopasov V.V., Tkacheva N.V.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.neuro-journal.ru/jour/article/view/15">https://www.neuro-journal.ru/jour/article/view/15</self-uri><abstract><sec><title>Введение</title><p>Введение. Пороки развития экто- и мезодермальных структур представляют собой разнообразные формы нарушения внутриутробного системного и локального морфогенеза, возникающие в различные сроки эмбрионального развития под влиянием факторов окружающей среды, геномных, хромосомных или генных мутаций. Разрегулирование клеточных функций вследствие мутаций и накопления дефектных белков инициирует опухолевую трансформацию тканей. Примером служат наследственные заболевания экто- и мезодермального происхождения — факоматозы (гамартоматозы).</p><p>Целью исследования явилось определение органоспецифичности, клинических проявлений, морфологических особенностей и степени прогрессии опухолей нервной системы и внутренних органов при наследственных заболеваниях экто- и мезодермального происхождения. </p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. Обследовано 103 больных с наследственными факоматозами. Всем пациентам проводилось комплексное клинико-визуализационное обследование, в том числе магнитно-резонансная томография, эхокардиоскопия, ультразвуковое исследование органов брюшной полости, почек, забрюшинного пространства, компьютерная томография брюшной полости и легких.</p></sec><sec><title>Результаты</title><p>Результаты. Причиной обращения больных было возникновение очаговых неврологических симптомов, фокальных и/или генерализованных эпилептических приступов. Клинические проявления определялись формой заболевания. Риск развития и прогрессирования различных новообразований наиболее высок при нейрофиброматозе I и II типов, туберозном склерозе, нейрокожном меланозе, множественной эндокринной неоплазии, ангиоматозах Гиппеля–Линдау, Луи–Бара. Благоприятное доброкачественное и стабильное течение, низкий злокачественный потенциал — отличительные признаки пигментоваскулярных факоматозов I–V типов.</p></sec><sec><title>Заключение</title><p>Заключение. Знание клинических проявлений различных пороков развития кожи, сосудов, нервной системы, ассоциированных с опухолевым ростом в клетках и тканях, практически значимо. Ранняя диагностика, использование современных технологий консервативного и хирургического лечения позволяют достичь прогнозируемого результата, предотвратить развитие тяжелых осложнений, существенно улучшить качество жизни больных с этой патологией.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Introduction</title><p>Introduction. Malformations of ecto- and mesodermal structures represent various forms of abnormality of intrauterine systemic and local morphogenesis, arising at different times of embryonic development due to environmental factors, genomic, chromosomal or gene mutations. Dysregulation of cellular functions due to mutations and accumulation of defective proteins initiates tumor transformation of tissues e.g. hereditary diseases of ectomesodermal origin — phakomatosis (hamartomatosis). </p><p>The aim of the study was to determine organ specificity, clinical manifestations, morphological features and the degree of progression of tumors of the nervous system and internal organs in hereditary diseases of ectomesodermal origin.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. 103 patients with hereditary phakomatosis were examined. All of them underwent a comprehensive clinical imaging examination, including magnetic resonance imaging, echocardioscopy, ultrasound examination of the abdominal organs, kidneys, retroperitoneal space, and computed tomography of the abdominal cavity and lungs.</p></sec><sec><title>Results</title><p>Results. The reason for the treatment of patients was the occurrence of focal neurological symptoms, focal and/or generalized epileptic seizures. Clinical manifestations were determined by the form of the disease. The risk of the development and progression of various neoplasms is the highest in neurofibromatosis type I–II, tuberous sclerosis, neurocutaneous melanosis, multiple endocrine neoplasia, angiomatosis of Hippel–Lindau, Louis-Bar . Favorable benign and stable course, low malignant potential are distinguishing characteristics of pigment-vascular phakomatoses type I–V.</p></sec><sec><title>Conclusion</title><p>Conclusion. Knowledge of the clinical manifestations of various malformations of the skin, blood vessels, and the nervous system associated with tumor growth in cells and tissues is practically significant. Early diagnosis and the use of modern technologies of conservative and surgical treatment allow achieving a predictable result, prevent the development of severe complications, and significantly improve the quality of life of patients with this pathology.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>эктодерма</kwd><kwd>экзодерма</kwd><kwd>факоматозы</kwd><kwd>опухоли нервной системы</kwd><kwd>опухоли внутренних органов</kwd><kwd>мезодерма</kwd></kwd-group><kwd-group xml:lang="en"><kwd>ectoderm</kwd><kwd>mesoderm</kwd><kwd>phakomatoses</kwd><kwd>tumors of the nervous system and internal organs</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Скворцов И.А. Неврология развития: Руководство для врачей. М.: Литтера; 2008.</mixed-citation><mixed-citation xml:lang="en">Skvortsov I.A. Neurology of Development: A Guide for Physicians [Nevrologiya razvitiya: Rukovodstvo dlya vrachey]. Moscow: Littera; 2008. (in Russian)</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Баранов В.С., Баранова Е.В., Иващенко Т.Э., Асеев М.В. Генетика человека и гены предрасположенности: Введение в предиктивную медицину. СПб.: Интермедика; 2000.</mixed-citation><mixed-citation xml:lang="en">Baranov V.S., Baranova E.V., Ivashchenko T.E., Aseev M.V. Human Genetics and Predisposition Genes (An Introduction to Predictive Medi­cine) [Genetika cheloveka i geny predraspolozhennosti: Vvedenie v prediktivnuyu meditsinu)]. St. Petersburg: Intermedika; 2000. (in Russian)</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Барашнев Ю.И., Бахарев В.А. Эмбриофетопатии. Диагностика и профилактика аномалий центральной нервной системы и скелета. М.: Триада-Х; 2010.</mixed-citation><mixed-citation xml:lang="en">Barashnev Yu.I., Bakharev V.A. Embryophetopathy. Diagnostics and Prevention of Anomalies of the Central Nervous System and Skeleton [Embriofetopatii. Diagnostika i profilaktika anomaliy tsentral’noy nervnoy sistemy i skeleta]. Moscow: Triada-Kh; 2010. (in Russian)</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Заридзе Д.Г. Канцерогенез. М.: Медицина; 2004.</mixed-citation><mixed-citation xml:lang="en">Zaridze D.G. Carcinogenesis [Kantserogenez]. Moscow: Meditsina; 2004. (in Russian)</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Darrah R., Quaghebeur G. Intra-cranial manifestations of the neurocutaneous syndromes. Clin. Radiol. 2000; 55(2): 82-98. https://doi.org/10.1053/crad.1999.0328</mixed-citation><mixed-citation xml:lang="en">Darrah R., Quaghebeur G. Intra-cranial manifestations of the neurocutaneous syndromes. Clin. Radiol. 2000; 55(2): 82-98. https://doi.org/10.1053/crad.1999.0328</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Мордовцев В.Н., Мордовцева В.В., Мордовцева В.В. Наследственные болезни и пороки развития кожи: Атлас. М.: Наука; 2004.</mixed-citation><mixed-citation xml:lang="en">Mordovtsev V.N., Mordovtseva V.V., Mordovtseva V.V. Hereditary Diseases and Skin Defects. Atlas [Nasledstvennye bolezni i poroki razvitiya kozhi: Atlas]. Moscow: Nauka; 2004. (in Russian)</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Галил-Оглы Г.А., Молочков В.А., Сергеев Ю.В. Дерматоонкология. Практическое руководство. М.: Медицина для всех; 2005.</mixed-citation><mixed-citation xml:lang="en">Galil-Ogly G.A., Molochkov V.A., Sergeev Yu.V. Dermatooncology. A Practical Guide [Dermatoonkologiya. Prakticheskoe rukovodstvo]. Moscow: Meditsina dlya vsekh; 2005. (in Russian)</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Джонс К.Л. Наследственные синдромы по Дэвиду Смиту. Атлас-справочник. Пер. с англ. М.: Практика; 2011.</mixed-citation><mixed-citation xml:lang="en">Jones K.L. Recognizable Patterns of Human Malformation: Genetic, Embryologic and Clinical Aspects. Philadelphia: Saunders; 1982.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Ламоткин И.А. Клиническая дерматоонкология. Атлас. М.: Бином. Лаборатория знаний; 2013.</mixed-citation><mixed-citation xml:lang="en">Lamotkin I.A. Clinical Dermato-Oncology. Atlas [Klinicheskaya dermatoonkologiya. Atlas]. Moscow: Binom. Laboratoriya znaniy; 2013. (in Russian)</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Albers A.C., Gutmann D.H. Gliomas in patients with neurofibromatosis type 1. Expert Rev. Neurother. 2009; 9(4): 535-9. https://doi.org/10.1586/ern.09.4</mixed-citation><mixed-citation xml:lang="en">Albers A.C., Gutmann D.H. Gliomas in patients with neurofibromatosis type 1. Expert Rev. Neurother. 2009; 9(4): 535-9. https://doi.org/10.1586/ern.09.4</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Graf N. Glioblastoma in children with NF1: the need for basic research. Pediatr. Blood Cancer. 2010; 54(7): 870-1. https://doi.org/10.1002/pbc.22487</mixed-citation><mixed-citation xml:lang="en">Graf N. Glioblastoma in children with NF1: the need for basic research. Pediatr. Blood Cancer. 2010; 54(7): 870-1. https://doi.org/10.1002/pbc.22487</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Hekmatnia A., Ghazavi A., Marashi Shooshtari M.J., Hekmatnia F., Basiratnia R. Imaging review of neurofibromatosis: helpful aspects for early detection. Iran J. Radiol. 2011; 8(2): 63-74.</mixed-citation><mixed-citation xml:lang="en">Hekmatnia A., Ghazavi A., Marashi Shooshtari M.J., Hekmatnia F., Basiratnia R. Imaging review of neurofibromatosis: helpful aspects for early detection. Iran J. Radiol. 2011; 8(2): 63-74.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Pascual-Castroviejo I., Pascual-Pascual S.I. Neurofibromatosis type 1 (NF1) associated with tumor of the corpus callosum. Childs Nerv. Syst. 2012; 28(12): 2177-80. https://doi.org/10.1007/s00381-012-1903-9</mixed-citation><mixed-citation xml:lang="en">Pascual-Castroviejo I., Pascual-Pascual S.I. Neurofibromatosis type 1 (NF1) associated with tumor of the corpus callosum. Childs Nerv. Syst. 2012; 28(12): 2177-80. https://doi.org/10.1007/s00381-012-1903-9</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Rasmussen S.A., Friedman J.M. NF1 gene and neurofibromatosis 1. Am. J. Epidemiol. 2000; 151(1): 33-40. https://doi.org/10.1093/oxfordjournals.aje.a010118</mixed-citation><mixed-citation xml:lang="en">Rasmussen S.A., Friedman J.M. NF1 gene and neurofibromatosis 1. Am. J. Epidemiol. 2000; 151(1): 33-40. https://doi.org/10.1093/oxfordjournals.aje.a010118</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Brems H., Beert E., de Ravel T., Legius E. Mechanisms in the pathogenesis of malignant tumours in neurofibromatosis type 1. Lancet Oncol. 2009; 10(5): 508-15. https://doi.org/10.1016/S1470-2045(09)70033-6</mixed-citation><mixed-citation xml:lang="en">Brems H., Beert E., de Ravel T., Legius E. Mechanisms in the pathogenesis of malignant tumours in neurofibromatosis type 1. Lancet Oncol. 2009; 10(5): 508-15. https://doi.org/10.1016/S1470-2045(09)70033-6</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Коновалов А.Н., Корниенко В.Н., Пронин И.Н. Магнитно-резонансная томография в нейрохирургии. М.: Видар; 1997.</mixed-citation><mixed-citation xml:lang="en">Konovalov A.N., Kornienko V.N., Pronin I.N. Magnetic Resonance Imaging in Neurosurgery [Magnitno-rezonansnaya tomografiya v neyrokhirurgii]. Moscow: Vidar; 1997. (in Russian)</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Коновалов А.Н., Корниенко В.Н., Озерова В.И., Пронин И.Н. Нейрорентгенология детского возраста. М.: Антидор; 2001.</mixed-citation><mixed-citation xml:lang="en">Konovalov A.N., Kornienko V.N., Ozerova V.I., Pronin I.N. Pediatric Neuroradiology [Neyrorentgenologiya detskogo vozrasta]. Moscow: Antidor; 2001. (in Russian)</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Guillamo J.S., Créange A., Kalifa C., Grill J., Rodriguez D., Doz F., et al. Prognostic factors of CNS tumours in Neurofibromatosis 1 (NF1): a retrospective study of 104 patients. Brain. 2003; 126(Pt. 1): 152-60. https://doi.org/10.1093/brain/awg016</mixed-citation><mixed-citation xml:lang="en">Guillamo J.S., Créange A., Kalifa C., Grill J., Rodriguez D., Doz F., et al. Prognostic factors of CNS tumours in Neurofibromatosis 1 (NF1): a retrospective study of 104 patients. Brain. 2003; 126(Pt. 1): 152–60. https://doi.org/10.1093/brain/awg016</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Tonsgard J.H. Clinical manifestations and management of neurofibromatosis type 1. Semin. Pediatr. Neurol. 2006; 13(1): 2-7. https://doi.org/10.1016/j.spen.2006.01.005</mixed-citation><mixed-citation xml:lang="en">Tonsgard J.H. Clinical manifestations and management of neurofibromatosis type 1. Semin. Pediatr. Neurol. 2006; 13(1): 2-7. https://doi.org/10.1016/j.spen.2006.01.005</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Гринберг М.С. Нейрохирургия. Пер. с англ. М.: МЕДпресс-информ; 2010.</mixed-citation><mixed-citation xml:lang="en">Greenberg M.S. Handbook of Neurosurgery. New York: Thieme Medi­cal Publishers; 2001.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Rosenfeld A., Listernick R., Charrow J., Goldman S. Neurofibromatosis type 1 and high-grade tumors of the central nervous system. Childs Nerv. Syst. 2010; 26(5): 663-7. https://doi.org/10.1007/s00381-009-1024-2</mixed-citation><mixed-citation xml:lang="en">Rosenfeld A., Listernick R., Charrow J., Goldman S. Neurofibromatosis type 1 and high-grade tumors of the central nervous system. Childs Nerv. Syst. 2010; 26(5): 663-7. https://doi.org/10.1007/s00381-009-1024-2</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Gokce G., Ceylan O.M., Mutlu F.M., Altinsoy H.I. Intracranial meningiomas and neurofibromatosis type 2. Acta Neurochir. (Wien). 2014; 156(6): 1103. https://doi.org/10.1007/s00701-014-2069-x</mixed-citation><mixed-citation xml:lang="en">Gokce G., Ceylan O.M., Mutlu F.M., Altinsoy H.I. Intracranial meningiomas and neurofibromatosis type 2. Acta Neurochir. (Wien). 2014; 156(6): 1103. https://doi.org/10.1007/s00701-014-2069-x</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Varan A., Şen H., Aydın B., Yalçın B., Kutluk T., Akyüz C. Neurofibromatosis type 1 and malignancy in childhood. Clin. Genet. 2016; 89(3): 341-5. https://doi.org/10.1111/cge.12625</mixed-citation><mixed-citation xml:lang="en">Varan A., Şen H., Aydın B., Yalçın B., Kutluk T., Akyüz C. Neurofibromatosis type 1 and malignancy in childhood. Clin. Genet. 2016; 89(3): 341-5. https://doi.org/10.1111/cge.12625</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Cuccia V., Zucaro G., Sosa F., Monges J., Lubienieky F., Taratuto A.L. Subependymal giant cell astrocytoma in children with tuberous sclerosis. Childs Nerv. Syst. 2003; 19(4): 232-43. https://doi.org/10.1007/s00381-002-0700-2</mixed-citation><mixed-citation xml:lang="en">Cuccia V., Zucaro G., Sosa F., Monges J., Lubienieky F., Taratuto A.L. Subependymal giant cell astrocytoma in children with tuberous sclerosis. Childs Nerv. Syst. 2003; 19(4): 232-43. https://doi.org/10.1007/s00381-002-0700-2</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Kassiri J., Snyder T.J., Bhargava R., Wheatley B.M., Sinclair D.B. Cortical tubers, cognition, and epilepsy in tuberous sclerosis. Pediatr. Neurol. 2011; 44(5): 328-32. https://doi.org/10.1016/j.pediatrneurol.2011.01.001</mixed-citation><mixed-citation xml:lang="en">Kassiri J., Snyder T.J., Bhargava R., Wheatley B.M., Sinclair D.B. Cortical tubers, cognition, and epilepsy in tuberous sclerosis. Pediatr. Neurol. 2011; 44(5): 328-32. https://doi.org/10.1016/j.pediatrneurol.2011.01.001</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Mukhin K.Yu, Kholin A.A., Mironov M.B., Petrukhin A.S., Holthausen H. Epileptic Encephalopathies and Related Syndromes in Children. Paris: John Libbey Eurotext; 2014.</mixed-citation><mixed-citation xml:lang="en">Mukhin K.Yu, Kholin A.A., Mironov M.B., Petrukhin A.S., Holthausen H. Epileptic Encephalopathies and Related Syndromes in Children. Paris: John Libbey Eurotext; 2014.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Дорофеева М.Ю., ред. Туберозный склероз. М.: Практическая медицина; 2012.</mixed-citation><mixed-citation xml:lang="en">Dorofeeva M.Yu., ed. Tuberous Sclerosis [Tuberoznyy skleroz]. Moscow: Prakticheskaya meditsina; 2012. (in Russian)</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Aslan E., Sap F., Sert A., Odabas D. Tuberous sclerosis and cardiac tumors: new electrocardiographic finding in an infant. Tex. Heart Inst. J. 2014; 41(5): 530-2. https://doi.org/10.14503/THIJ-13-3571</mixed-citation><mixed-citation xml:lang="en">Aslan E., Sap F., Sert A., Odabas D. Tuberous sclerosis and cardiac tumors: new electrocardiographic finding in an infant. Tex. Heart Inst. J. 2014; 41(5): 530-2. https://doi.org/10.14503/THIJ-13-3571</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Mei M., Rosen L.E., Reddy V., Cimbaluk D.J., Gattuso P. Concurrent angiomyolipomas and renal cell neoplasms in patients without tuberous sclerosis: a retrospective study. Int. J. Surg. Pathol. 2015; 23(4): 265-70. https://doi.org/10.1177/1066896915569914</mixed-citation><mixed-citation xml:lang="en">Mei M., Rosen L.E., Reddy V., Cimbaluk D.J., Gattuso P. Concurrent angiomyolipomas and renal cell neoplasms in patients without tuberous sclerosis: a retrospective study. Int. J. Surg. Pathol. 2015; 23(4): 265-70. https://doi.org/10.1177/1066896915569914</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Grajkowska W., Kotulska K., Jurkiewicz E., Matyja E. Brain lesions in tuberous sclerosis complex. Review. Folia Neuropathol. 2010; 48(3): 139-49.</mixed-citation><mixed-citation xml:lang="en">Grajkowska W., Kotulska K., Jurkiewicz E., Matyja E. Brain lesions in tuberous sclerosis complex. Review. Folia Neuropathol. 2010; 48(3): 139-49.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Jung T.Y., Kim Y.H., Jung S., Baek H.J., Lee K.H. The clinical characteristics of subependymal giant cell astrocytoma: five cases. Brain Tumor Res. Treat. 2015; 3(1): 44-7. https://doi.org/10.14791/btrt.2015.3.1.44</mixed-citation><mixed-citation xml:lang="en">Jung T.Y., Kim Y.H., Jung S., Baek H.J., Lee K.H. The clinical characteristics of subependymal giant cell astrocytoma: five cases. Brain Tumor Res. Treat. 2015; 3(1): 44-7. https://doi.org/10.14791/btrt.2015.3.1.44</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Kim J.K., Park S.Y., Shon J.H., Cho K.S. Angiomyolipoma with minimal fat: differentiation from renal cell carcinoma at biphasic helical CT. Radiology. 2004; 230(3): 677-84. https://doi.org/10.1148/radiol.2303030003</mixed-citation><mixed-citation xml:lang="en">Kim J.K., Park S.Y., Shon J.H., Cho K.S. Angiomyolipoma with minimal fat: differentiation from renal cell carcinoma at biphasic helical CT. Radiology. 2004; 230(3): 677-84. https://doi.org/10.1148/radiol.2303030003</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Leung A.K., Robson W.L. Tuberous sclerosis complex: a review. J. Pediatr. Health Care. 2007; 21(2): 108-14. https://doi.org/10.1016/j.pedhc.2006.05.004</mixed-citation><mixed-citation xml:lang="en">Leung A.K., Robson W.L. Tuberous sclerosis complex: a review. J. Pediatr. Health Care. 2007; 21(2): 108-14. https://doi.org/10.1016/j.pedhc.2006.05.004</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Goh S., Butler W., Thiele E.A. Subependymal giant cell tumors in tuberous sclerosis complex. Neurology. 2004; 63(8): 1457-61. https://doi.org/10.1212/01.wnl.0000142039.14522.1a</mixed-citation><mixed-citation xml:lang="en">Goh S., Butler W., Thiele E.A. Subependymal giant cell tumors in tuberous sclerosis complex. Neurology. 2004; 63(8): 1457-61. https://doi.org/10.1212/01.wnl.0000142039.14522.1a</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Adriaensen M.E., Schaefer-Prokop C.M., Stijnen T., Duyndam D.A., Zonnenberg B.A., Prokop M. Prevalence of subependymal giant cell tumors in patients with tuberous sclerosis and a review of the literature. Eur. J. Neurol. 2009; 16(6): 691-6. https://doi.org/10.1111/j.1468-1331.2009.02567.x</mixed-citation><mixed-citation xml:lang="en">Adriaensen M.E., Schaefer-Prokop C.M., Stijnen T., Duyndam D.A., Zonnenberg B.A., Prokop M. Prevalence of subependymal giant cell tumors in patients with tuberous sclerosis and a review of the literature. Eur. J. Neurol. 2009; 16(6): 691-6. https://doi.org/10.1111/j.1468-1331.2009.02567.x</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Reyes D., Prayson R. Glioblastoma in the setting of tuberous sclerosis. J. Clin. Neurosci. 2015; 22(5): 907-8. https://doi.org/10.1016/j.jocn.2014.12.001</mixed-citation><mixed-citation xml:lang="en">Reyes D., Prayson R. Glioblastoma in the setting of tuberous sclerosis. J. Clin. Neurosci. 2015; 22(5): 907-8. https://doi.org/10.1016/j.jocn.2014.12.001</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Maria B.L., Deidrick K.M., Roach E.S., Gutmann D.H. Tuberous sclerosis complex: pathogenesis, diagnosis, strategies, therapies, and future research directions. J. Child Neurol. 2004; 19(9): 632-42. https://doi.org/10.1177/08830738040190090201</mixed-citation><mixed-citation xml:lang="en">Maria B.L., Deidrick K.M., Roach E.S., Gutmann D.H. Tuberous sclerosis complex: pathogenesis, diagnosis, strategies, therapies, and future research directions. J. Child Neurol. 2004; 19(9): 632-42. https://doi.org/10.1177/08830738040190090201</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Jozwiak J., Jozwiak S., Oldak M. Molecular activity of sirolimus and its possible application in tuberous sclerosis treatment. Med. Res. Rev. 2006; 26(2): 160-80. https://doi.org/10.1002/med.20049</mixed-citation><mixed-citation xml:lang="en">Jozwiak J., Jozwiak S., Oldak M. Molecular activity of sirolimus and its possible application in tuberous sclerosis treatment. Med. Res. Rev. 2006; 26(2): 160-80. https://doi.org/10.1002/med.20049</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Bissler J.J., McCormack F.X., Young L.R., lwing J.M., Chuck G., Leonard J.M., et al. Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis. N. Engl. J. Med. 2008; 358(2): 140-51. https://doi.org/10.1056/NEJMoa063564</mixed-citation><mixed-citation xml:lang="en">Bissler J.J., McCormack F.X., Young L.R., lwing J.M., Chuck G., Leonard J.M., et al. Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis. N. Engl. J. Med. 2008; 358(2): 140-51. https://doi.org/10.1056/NEJMoa063564</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Zitterbart K. Subependymal giant cell astrocytoma associated with tuberous sclerosis complex - pharmacological treatment using mTOR inhibitors. Klin. Onkol. 2014; 27(6): 401-5. https://doi.org/10.14735/amko2014401 (in Czech)</mixed-citation><mixed-citation xml:lang="en">Zitterbart K. Subependymal giant cell astrocytoma associated with tuberous sclerosis complex – pharmacological treatment using mTOR inhibitors. Klin. Onkol. 2014; 27(6): 401-5. https://doi.org/10.14735/amko2014401 (in Czech)</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Trelinska J., Dachowska I., Kotulska K., Baranska D., Fendler W., Jozwiak S., et al. Factors affecting response to everolimus therapy for subependymal giant cell astrocytomas associated withtuberous sclerosis. Pediatr. Blood Cancer. 2015; 62(4): 616-21. https://doi.org/10.1002/pbc.25368</mixed-citation><mixed-citation xml:lang="en">Trelinska J., Dachowska I., Kotulska K., Baranska D., Fendler W., Jozwiak S., et al. Factors affecting response to everolimus therapy for subependymal giant cell astrocytomas associated withtuberous sclerosis. Pediatr. Blood Cancer. 2015; 62(4): 616-21. https://doi.org/10.1002/pbc.25368</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Seckin D., Yucelten D., Aytug A., Demirkesen C. Phacomatosis pigmentovascularis type IIIb. Int. J. Dermatol. 2007; 46(9): 960-3. https://doi.org/10.1111/j.1365-4632.2007.03121.x</mixed-citation><mixed-citation xml:lang="en">Seckin D., Yucelten D., Aytug A., Demirkesen C. Phacomatosis pigmentovascularis type IIIb. Int. J. Dermatol. 2007; 46(9): 960-3. https://doi.org/10.1111/j.1365-4632.2007.03121.x</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Fernández-Guarino M., Boixeda P., de Las Heras E., Aboin S., Garcia-Millán C., Olasolo P.J. Phacomatosis pigmentovascularis: Clinical findings in 15 patients and review of the literature. J. Am. Acad. Dermatol. 2008; 58(1): 88-93. https://doi.org/10.1016/j.jaad.2007.08.012</mixed-citation><mixed-citation xml:lang="en">Fernández-Guarino M., Boixeda P., de Las Heras E., Aboin S., Garcia-Millán C., Olasolo P.J. Phacomatosis pigmentovascularis: Clinical findings in 15 patients and review of the literature. J. Am. Acad. Dermatol. 2008; 58(1): 88–93. https://doi.org/10.1016/j.jaad.2007.08.012</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Smith J.R., Moore M.M., Stetson C.L. JAAD grand rounds quiz. Red, purple, and brown skin lesions in a 2-month-old boy. Phakomatosis pigmentovascularis type V. J. Am. Acad. Dermatol. 2012; 66(2): 341-2. https://doi.org/10.1016/j.jaad.2010.09.008</mixed-citation><mixed-citation xml:lang="en">Smith J.R., Moore M.M., Stetson C.L. JAAD grand rounds quiz. Red, purple, and brown skin lesions in a 2-month-old boy. Phakomatosis pigmentovascularis type V. J. Am. Acad. Dermatol. 2012; 66(2): 341-2. https://doi.org/10.1016/j.jaad.2010.09.008</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Ünlü E., Şahin T.A. Neonatal case of Phacomatosis pigmentovascularis Type IIa. Balkan Med. J. 2015; 32(1): 129-30. https://doi.org/10.5152/balkanmedj.2015.15448</mixed-citation><mixed-citation xml:lang="en">Ünlü E., Şahin T.A. Neonatal case of Phacomatosis pigmentovascularis Type IIa. Balkan Med. J. 2015; 32(1): 129-30. https://doi.org/10.5152/balkanmedj.2015.15448</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Jun H.J., Kim S.M., Cho S.H., Lee J.D., Kim H.S. Phacomatosis Pigmentovascularis type Vb in a three-year old boy. Ann. Dermatol. 2015; 27(3): 353-4. https://doi.org/10.5021/ad.2015.27.3.353</mixed-citation><mixed-citation xml:lang="en">Jun H.J., Kim S.M., Cho S.H., Lee J.D., Kim H.S. Phacomatosis Pigmentovascularis type Vb in a three-year old boy. Ann. Dermatol. 2015; 27(3): 353-4. https://doi.org/10.5021/ad.2015.27.3.353</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Iourov I.Y., Vorsanova S.G., Yurov Y.B. Somatic Genome Variations. Chichester: John Wiley &amp; Sons Ltd.; 2012.</mixed-citation><mixed-citation xml:lang="en">Iourov I.Y., Vorsanova S.G., Yurov Y.B. Somatic Genome Variations. Chichester: John Wiley &amp; Sons Ltd.; 2012.</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Andrs M., Korabecny J., Nepovimova E., Jun D., Hodny Z., Moravcova S., et al. The development of ataxia telangiectasia mutated kinase inhibitors. Mini Rev. Med. Chem. 2014; 14(10): 805-11.</mixed-citation><mixed-citation xml:lang="en">Andrs M., Korabecny J., Nepovimova E., Jun D., Hodny Z., Moravcova S., et al. The development of ataxia telangiectasia mutated kinase inhibitors. Mini Rev. Med. Chem. 2014; 14(10): 805-11.</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Wong H.S., Abdul Rahman R., Choo S.Y., Yahya N. Sturge-Weber-Syndrome with extreme ocular manifestation and rare association of upper airway angioma with anticipated difficult airway. Med. J. Malaysia. 2012; 67(4): 435-7.</mixed-citation><mixed-citation xml:lang="en">Wong H.S., Abdul Rahman R., Choo S.Y., Yahya N. Sturge-Weber-Syndrome with extreme ocular manifestation and rare association of upper airway angioma with anticipated difficult airway. Med. J. Malaysia. 2012; 67(4): 435-7.</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Recupero S.M., Abdolrahimzadeh S., De Dominicis M., Mollo R. Sturge-Weber syndrome associated with naevus of Ota. Eye (Lond). 1998; 12(Pt. 2): 212-3. https://doi.org/10.1038/eye.1998.50</mixed-citation><mixed-citation xml:lang="en">Recupero S.M., Abdolrahimzadeh S., De Dominicis M., Mollo R. Sturge-Weber syndrome associated with naevus of Ota. Eye (Lond). 1998; 12(Pt. 2): 212-3. https://doi.org/10.1038/eye.1998.50</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Değerliyurt A., Kantar A., Ceylaner S., Aysun S. Hypomelanosis of Ito and Sturge-Weber syndrome without facial nevus: an association or a new syndrome? Pediatr. Neurol. 2009; 40(5): 395-7. https://doi.org/10.1016/j.pediatrneurol.2008.11.017</mixed-citation><mixed-citation xml:lang="en">Değerliyurt A., Kantar A., Ceylaner S., Aysun S. Hypomelanosis of Ito and Sturge-Weber syndrome without facial nevus: an association or a new syndrome? Pediatr. Neurol. 2009; 40(5): 395-7. https://doi.org/10.1016/j.pediatrneurol.2008.11.017</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Irimia A., Preda M., Ciuca C.A., Gavrila C.D. Sturge Weber syndrome in association with oculo-dermal melanosis. Oftalmologia. 2007; 51(3): 45-9. (in Romanian)</mixed-citation><mixed-citation xml:lang="en">Irimia A., Preda M., Ciuca C.A., Gavrila C.D. Sturge Weber syndrome in association with oculo-dermal melanosis. Oftalmologia. 2007; 51(3): 45-9. (in Romanian)</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Rodríguez-Bujaldón A.L., Vázquez-Bayo C., Jiménez-Puya R.J., Moreno-Giménez J.C. Sturge-Weber syndrome and type 1 neurofibromatosis: a chance association? Actas Dermosifiliogr. 2008; 99(4): 313-4. (in Spanish)</mixed-citation><mixed-citation xml:lang="en">Rodríguez-Bujaldón A.L., Vázquez-Bayo C., Jiménez-Puya R.J., Moreno-Giménez J.C. Sturge-Weber syndrome and type 1 neurofibromatosis: a chance association? Actas Dermosifiliogr. 2008; 99(4): 313-4. (in Spanish)</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Mahmood A., Dujovny M., Chason J.L., Zamorano L.J. Sturge-Weber-Dimitri disease? In association with an astrocytoma. Acta Neurochir. (Wien). 1991; 110(1-2): 87-9. https://doi.org/10.1007/BF01402053</mixed-citation><mixed-citation xml:lang="en">Mahmood A., Dujovny M., Chason J.L., Zamorano L.J. Sturge-Weber-Dimitri disease? In association with an astrocytoma. Acta Neurochir. (Wien). 1991; 110(1-2): 87-9. https://doi.org/10.1007/BF01402053</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Kilickesmez O., Sanal H.T., Haholu A., Kocamaz E. Coexistence of pleomorphic xanthoastrocytoma with Sturge-Weber syndrome: MRI features. Pediatr. Radiol. 2005; 35(9): 910-3. https://doi.org/10.1007/s00247-005-1480-0</mixed-citation><mixed-citation xml:lang="en">Kilickesmez O., Sanal H.T., Haholu A., Kocamaz E. Coexistence of pleomorphic xanthoastrocytoma with Sturge-Weber syndrome: MRI features. Pediatr. Radiol. 2005; 35(9): 910-3. https://doi.org/10.1007/s00247-005-1480-0</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Curatolo P. MRI appearance of Sturge-Weber syndrome in tuberous sclerosis complex: is the neural crest the culprit? J. Child Neurol. 2009; 24(3): 263-6. https://doi.org/10.1177/0883073808324220</mixed-citation><mixed-citation xml:lang="en">Curatolo P. MRI appearance of Sturge-Weber syndrome in tuberous sclerosis complex: is the neural crest the culprit? J. Child Neurol. 2009; 24(3): 263-6. https://doi.org/10.1177/0883073808324220</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Morana G., Mancardi M.M., Baglietto M.G., Rossi A. Focal leptomeningeal enhancement and corticopial calcifications underlying a parietal convexity lipoma: a rare association of findings in 2 pediatric epileptic patients. J. Child Neurol. 2011; 26(5): 634-7. https://doi.org/10.1177/0883073810387665</mixed-citation><mixed-citation xml:lang="en">Morana G., Mancardi M.M., Baglietto M.G., Rossi A. Focal leptomeningeal enhancement and corticopial calcifications underlying a parietal convexity lipoma: a rare association of findings in 2 pediatric epileptic patients. J. Child Neurol. 2011; 26(5): 634-7. https://doi.org/10.1177/0883073810387665</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Overdiek A., Feifel H., Schaper J., Mayatepek E., Rosenbaum T. Diagnostic delay of NF1 in hemifacial hypertrophy due to plexiform neurofibromas. Brain Dev. 2006; 28(5): 275-80. https://doi.org/10.1016/j.braindev.2005.10.001</mixed-citation><mixed-citation xml:lang="en">Overdiek A., Feifel H., Schaper J., Mayatepek E., Rosenbaum T. Diagnostic delay of NF1 in hemifacial hypertrophy due to plexiform neurofibromas. Brain Dev. 2006; 28(5): 275-80. https://doi.org/10.1016/j.braindev.2005.10.001</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Ricalde P., Magliocca K.R., Lee J.S. Craniofacial fibrous dysplasia. Oral. Maxillofac. Surg. Clin. North Am. 2012; 24(3): 427-41. https://doi.org/10.1016/j.coms.2012.05.004</mixed-citation><mixed-citation xml:lang="en">Ricalde P., Magliocca K.R., Lee J.S. Craniofacial fibrous dysplasia. Oral. Maxillofac. Surg. Clin. North Am. 2012; 24(3): 427-41. https://doi.org/10.1016/j.coms.2012.05.004</mixed-citation></citation-alternatives></ref><ref id="cit60"><label>60</label><citation-alternatives><mixed-citation xml:lang="ru">Sen S., Bala S., Halder C., Ahar R., Gangopadhyay A. Phakomatosis pigmentovascularis presen-ting with sturge-weber syndrome and klippel-trenaunay syndrome. Indian J. Dermatol. 2015; 60(1): 77-9. https://doi.org/10.4103/0019-5154.147801</mixed-citation><mixed-citation xml:lang="en">Sen S., Bala S., Halder C., Ahar R., Gangopadhyay A. Phakomatosis pigmentovascularis presen-ting with sturge-weber syndrome and klippel-trenaunay syndrome. Indian J. Dermatol. 2015; 60(1): 77-9. https://doi.org/10.4103/0019-5154.147801</mixed-citation></citation-alternatives></ref><ref id="cit61"><label>61</label><citation-alternatives><mixed-citation xml:lang="ru">Trumpy I.G., Haakonsen M., Maehlen J., Lyberg T. Progressive facial hemiatrophy associated with an astrocytoma in the cerebellopontine region. J. Oral. Maxillofac. Surg. 2001; 59(6): 684-7. https://doi.org/10.1053/joms.2001.23404</mixed-citation><mixed-citation xml:lang="en">Trumpy I.G., Haakonsen M., Maehlen J., Lyberg T. Progressive facial hemiatrophy associated with an astrocytoma in the cerebellopontine region. J. Oral. Maxillofac. Surg. 2001; 59(6): 684-7. https://doi.org/10.1053/joms.2001.23404</mixed-citation></citation-alternatives></ref><ref id="cit62"><label>62</label><citation-alternatives><mixed-citation xml:lang="ru">Bergler-Czop B., Lis-Swiety A., Brzezińska-Wcisło L. Scleroderma linearis: hemiatrophia faciei progressiva (Parry-Romberg syndrom) without any changes in CNS and linear scleroderma “en coup de sabre” with CNS tumor. BMC Neurol. 2009; 9: 39. https://doi.org/10.1186/1471-2377-9-39</mixed-citation><mixed-citation xml:lang="en">Bergler-Czop B., Lis-Swiety A., Brzezińska-Wcisło L. Scleroderma linearis: hemiatrophia faciei progressiva (Parry-Romberg syndrom) without any changes in CNS and linear scleroderma "en coup de sabre" with CNS tumor. BMC Neurol. 2009; 9: 39. https://doi.org/10.1186/1471-2377-9-39</mixed-citation></citation-alternatives></ref><ref id="cit63"><label>63</label><citation-alternatives><mixed-citation xml:lang="ru">Geormăneanu M., Iagăru N., Popescu-Micloşanu S., Bădulescu M. Congenital hemihypertrophy. Tendency to association with other abnormalities and/or tumors. Morphol. Embryol. (Bucur). 1983; 29(1): 39-45.</mixed-citation><mixed-citation xml:lang="en">Geormăneanu M., Iagăru N., Popescu-Micloşanu S., Bădulescu M. Congenital hemihypertrophy. Tendency to association with other abnormalities and/or tumors. Morphol. Embryol. (Bucur). 1983; 29(1): 39-45.</mixed-citation></citation-alternatives></ref><ref id="cit64"><label>64</label><citation-alternatives><mixed-citation xml:lang="ru">Khan G.A., Melman A., Bank N. Renal involvement in neurocutaneous syndromes. J. Am. Soc. Nephrol. 1995; 5(7): 1411-7.</mixed-citation><mixed-citation xml:lang="en">Khan G.A., Melman A., Bank N. Renal involvement in neurocutaneous syndromes. J. Am. Soc. Nephrol. 1995; 5(7): 1411-7.</mixed-citation></citation-alternatives></ref><ref id="cit65"><label>65</label><citation-alternatives><mixed-citation xml:lang="ru">Sigillo R., Rivera H., Nikitakis N.G., Sauk J.J. Neurofibromatosis type 1: a clinicopathological study of the orofacial manifestations in 6 pediatric patients. Pediatr. Dent. 2002; 24(6): 575-80.</mixed-citation><mixed-citation xml:lang="en">Sigillo R., Rivera H., Nikitakis N.G., Sauk J.J. Neurofibromatosis type 1: a clinicopathological study of the orofacial manifestations in 6 pediatric patients. Pediatr. Dent. 2002; 24(6): 575-80.</mixed-citation></citation-alternatives></ref><ref id="cit66"><label>66</label><citation-alternatives><mixed-citation xml:lang="ru">Hunt J.A., Hobar P.C. Common craniofacial anomalies: conditions of craniofacial atrophy/hypoplasia and neoplasia. Plast. Reconstr. Surg. 2003; 111(4): 1497-510. https://doi.org/10.1097/01.PRS.0000049646.25757.BE</mixed-citation><mixed-citation xml:lang="en">Hunt J.A., Hobar P.C. Common craniofacial anomalies: conditions of craniofacial atrophy/hypoplasia and neoplasia. Plast. Reconstr. Surg. 2003; 111(4): 1497-510. https://doi.org/10.1097/01.PRS.0000049646.25757.BE</mixed-citation></citation-alternatives></ref><ref id="cit67"><label>67</label><citation-alternatives><mixed-citation xml:lang="ru">Лумента Х.Б., Ди Россо К., Хаасе Й., Моэй Я.Я.А. Нейрохирургия. Европейское руководство: в 2 томах. Том 2. Пер. с англ. М.: Издательство Панфилова; БИНОМ. Лаборатория знаний; 2013.</mixed-citation><mixed-citation xml:lang="en">Al-Aizari N.A., Azzeghaiby S.N., Al-Shamiri H.M., Darwish S., Tarakji B. Oral manifestations of Parry-Romberg syndrome: A review of literature. Avicenna J. Med. 2015; 5(2): 25-8. https://doi.org/10.4103/2231-0770.154193</mixed-citation></citation-alternatives></ref><ref id="cit68"><label>68</label><citation-alternatives><mixed-citation xml:lang="ru">Айкарди Ж. и др. Заболевания нервной системы у детей: в 2-х томах. Том 2. Пер. с англ. М.: Издательство Панфилова; БИНОМ. Лаборатория знаний; 2013.</mixed-citation><mixed-citation xml:lang="en">Lumenta C.B., Di Rocco C., Haase J., Mooij J.J.A., eds. Neurosurgery. European Manual of Medicine. Wien-New York: Springer; 2010.</mixed-citation></citation-alternatives></ref><ref id="cit69"><label>69</label><citation-alternatives><mixed-citation xml:lang="ru">Aicardi J., ed. Diseases of the Nervous System in Childhood. London: Mac Ketih Press; 2009.</mixed-citation><mixed-citation xml:lang="en">Aicardi J., ed. Diseases of the Nervous System in Childhood. London: Mac Ketih Press; 2009.</mixed-citation></citation-alternatives></ref><ref id="cit70"><label>70</label><citation-alternatives><mixed-citation xml:lang="ru">Weisbrod A.B., Kitano M., Thomas F., Williams D., Gulati N., Gesuwan K., et al. Assessment of tumor growth in pancreatic neuroendocrine tumors in von Hippel Lindau syndrome. J. Am. Coll. Surg. 2014; 218(2): 163-9. https://doi.org/10.1016/j.jamcollsurg.2013.10.025</mixed-citation><mixed-citation xml:lang="en">Weisbrod A.B., Kitano M., Thomas F., Williams D., Gulati N., Gesuwan K., et al. Assessment of tumor growth in pancreatic neuroendocrine tumors in von Hippel Lindau syndrome. J. Am. Coll. Surg. 2014; 218(2): 163-9. https://doi.org/10.1016/j.jamcollsurg.2013.10.025</mixed-citation></citation-alternatives></ref><ref id="cit71"><label>71</label><citation-alternatives><mixed-citation xml:lang="ru">Вулф К., Джонсон Р., Сюрмонд Д. Дерматология по Томасу Фицпатрику: Атлас-справочник. Пер. с англ. М.: Практика; 2007: 361-5.</mixed-citation><mixed-citation xml:lang="en">Cassol C., Mete O. Endocrine manifestations of von Hippel-Lindau disease. Arch. Pathol. Lab. Med. 2015; 139(2): 263-8. https://doi.org/10.5858/arpa.2013-0520-RS</mixed-citation></citation-alternatives></ref><ref id="cit72"><label>72</label><citation-alternatives><mixed-citation xml:lang="ru">Wolff K., Johnson R.A., Suurmond D. Fitzpatrick’s Color Atlas and Synopsis of Clinical Dermatology. New York: McGraw-Hill; 2005.</mixed-citation><mixed-citation xml:lang="en">Wolff K., Johnson R.A., Suurmond D. Fitzpatrick’s Color Atlas and Synopsis of Clinical Dermatology. New York: McGraw-Hill; 2005.</mixed-citation></citation-alternatives></ref><ref id="cit73"><label>73</label><citation-alternatives><mixed-citation xml:lang="ru">Белопасов В.В., Ткачева Н.В., Сопрунова И.В., Цоцонава Ж.М., Ажкамалов С.И. Болезнь Рокитанского (нейрокожный меланоз). Нейрохирургия и неврология детского возраста. 2012; (2-3): 36-43.</mixed-citation><mixed-citation xml:lang="en">Burrstein F., Seier H., Hudgins P.A., Zapiach L. Neurocutaneous melanosis. J. Craniofac. Surg. 2005; 16(5): 874-6. https://doi.org/10.1097/01.scs.0000181050.06696.4d</mixed-citation></citation-alternatives></ref><ref id="cit74"><label>74</label><citation-alternatives><mixed-citation xml:lang="ru">Корниенко В.Н., Серков С.В., Пронин И.Н., Коршунов А.Г., Эриксен М.Р. Нейрокожный меланоз в сочетании с интракраниальной беспигментной меланомой: (клиническое наблюдение). Медицинская визуализация. 2003; (3): 27-33.</mixed-citation><mixed-citation xml:lang="en">Belopasov V.V., Tkacheva N.V., Soprunova I.V., Tsotsonava Zh.M., Azhkamalov S.I. Rokitansky disease (neurocutaneous melanosis). Neyrokhirurgiya i nevrologiya detskogo vozrasta. 2012; (2-3): 36-43. (in Russian)</mixed-citation></citation-alternatives></ref><ref id="cit75"><label>75</label><citation-alternatives><mixed-citation xml:lang="ru">Kornienko V.N., Serkov S.V., Pronin I.N., Korshunov A.G., Eriksen M.R. Neurocutaneous melanosis and anaplastic melanoma of the brain (case report). Meditsinskaya vizualizatsiya. 2003; (3): 27-33. (in Russian)</mixed-citation><mixed-citation xml:lang="en">Kornienko V.N., Serkov S.V., Pronin I.N., Korshunov A.G., Eriksen M.R. Neurocutaneous melanosis and anaplastic melanoma of the brain (case report). Meditsinskaya vizualizatsiya. 2003; (3): 27-33. (in Russian)</mixed-citation></citation-alternatives></ref><ref id="cit76"><label>76</label><citation-alternatives><mixed-citation xml:lang="ru">Rao G.R., Durga Prasad B.K., Amareswar A., Vijaya K.T. Large congenital melanocytic nevus with metastatic melanoma with a probable primary in the lung. Indian J. Dermatol. Venereol. Leprol. 2011; 77(1): 51-4. https://doi.org/10.4103/0378-6323.74980</mixed-citation><mixed-citation xml:lang="en">Rao G.R., Durga Prasad B.K., Amareswar A., Vijaya K.T. Large congenital melanocytic nevus with metastatic melanoma with a probable primary in the lung. Indian J. Dermatol. Venereol. Leprol. 2011; 77(1): 51-4. https://doi.org/10.4103/0378-6323.74980</mixed-citation></citation-alternatives></ref><ref id="cit77"><label>77</label><citation-alternatives><mixed-citation xml:lang="ru">Тепляков В.В., Карпенко В.Ю., Седых С.А., Волченко Н.Н., Шаталов А.М., Епифанова С.В. Ошибки в диагностике и лечении сарком мягких тканей. Хирургия. Журнал им. Н.И. Пирогова. 2011; (1): 36-42.</mixed-citation><mixed-citation xml:lang="en">Teplyakov V.V., Karpenko V.Yu., Sedykh S.A., Volchenko N.N., Shatalov A.M., Epifanova S.V. Mistakes in diagnostics and treatment of soft tissue sarcomas. Khirurgiya. Zhurnal im. N.I. Pirogova. 2011; (1): 36-42. (in Russian)</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
